Foodtech startup Imagindairy receives FDA approval for animal-free milk proteins
Imagindairy creates animal-free milk proteins from microorganisms via proprietary precision-fermentation technology that allows the production of a broad spectrum of dairy analogs, from raw milk to cheese, without involving animals
Foodtech startup Imagindairy, which specializes in animal-free milk protein development, announced on Thursday that it has received FDA approval in the form of a "No Questions Letter", signifying the safety of its products for consumer use. This accomplishment paves the way for the company to explore commercial collaborations, market its products, and engage in sales with a diverse range of food companies in the American market.
Imagindairy creates animal-free milk proteins from microorganisms via proprietary precision-fermentation technology. The technology allows the production of a broad spectrum of dairy analogs, from raw milk to cheese, without involving animals. Imagindairy’s protein powder is non-GMO, cholesterol-free, and possess the same flavor, texture, functionality, and nutritional value as cow-based counterparts. Most importantly, the proteins eliminate the burden that livestock imposes on the environment.
The company's distinctive approach combines innovative artificial intelligence technology, developed through over 15 years of research at Tel Aviv University, with advanced biotechnological methods. This synergy enables Imagindairy to produce protein powder on an industrial scale at low costs.
Established in 2020 with the backing of the Strauss foodtech incubator, The Kitchen, by Dr. Eyal Afergan (CEO), Dr. Arie Abo (CTO), and Prof. Tamir Tuller (CSO), Imagindairy has raised over $30 million to date from the likes of Target Global, Strauss Group, Emerald Technology Ventures, Green Circle Foodtech Ventures, Collaborative Fund, New Climate Ventures, and FoodSparks by PeakBridge. The company employs over 30 people, and is headquartered in Haifa.
Related articles:
"We are very excited about receiving approval from the FDA, this is excellent news for the company, the foodtech industry and of course for consumers and the environment,” Afergan told Calcalist. “This is a significant milestone for the company towards the commercialization of our milk protein and entry into the American market. The FDA's approval allows us to collaborate with food brands and manufacturers to bring beloved dairy products such as milk, cream cheese, ice cream and yogurt to consumers, without the need for cows and without compromises in terms of taste and experience."
Afergan added that collaboration with food giants such as Danone and Strauss will allow the company to introduce its products to the market quickly and with minimal obstacles. "The world, as it is today, will not be able to meet the growing demand for food, without producing it in innovative ways. The way to strengthen nutritional and sustainable security is through advanced technologies that enable the production of nutritious and high-quality food, with minimal use of natural resources."
